Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Diabetes Mellitus, Type 2 1 Cushing Syndrome 1 ACTH Syndrome, Ectopic 1

Interventions

Cyclophosphamide 3162 Cisplatin 3160 Carboplatin 2938 Paclitaxel 2673 Radiotherapy 2648 Gemcitabine 2547 pembrolizumab 2330 Docetaxel 2157 Bevacizumab 2128 Fluorouracil 1822 Capecitabine 1782 Oxaliplatin 1713 Dexamethasone 1590 Nivolumab 1517 Doxorubicin 1477 Rituximab 1454 Etoposide 1342 Magnetic Resonance Spectroscopy 1266 Irinotecan 1235 Leucovorin 1216 Cytarabine 1123 Pemetrexed 1062 Drug Therapy 1062 fludarabine 1050 Vincristine 956 Specimen Handling 935 Prednisone 925 Cetuximab 921 Lenalidomide 916 Trastuzumab 901

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × ASP3662 × Clear all

NCT07296484 2026-05-12

CAPTAIN-T2D

Sparrow Pharmaceuticals

Phase 2 Recruiting

ACTH Syndrome, Ectopic, Cushing Syndrome, Diabetes Mellitus, Type 2

Data powered by HemOnc (CC BY 4.0) Colophon ⚡